On 23 July 2k19, UnitedHealth Group Incorporated (NYSE:UNH) shares price traded between $252.01 and $256.10 during the last trading session upbeat/downbeat with -0.12% at $255.01. The shares recorded trading volume 2,465,463 shares as compared to its average volume of 4,266,720 shares.
UnitedHealth Group (UNH) stated 2nd quarter 2k19 results with continued well diversified strength in performance. “Our results in the quarter reflect strong and balanced performance from both Optum and UnitedHealthcare and are driven by the 320,000 women and men of UnitedHealth Group who focus every day on creating value for those we serve,” stated David S. Wichmann, chief executive officer of UnitedHealth Group.
UnitedHealthcare grew second quarter 2k19 earnings from operations by 12.1 percent to $2.6B driven by revenue growth and strong cost disciplines. The business grew to serve 705,000 more people with medical benefits over the past year, including a greater mix of people with higher acuity needs, helping grow revenues by $2.7B, or 6.0 percent, to $48.6B in the quarter.
EPS growth for this year is 28.30% and EPS growth for next year is expected to reach at 12.47%. EPS growth in past five years was 17.30% while EPS growth in next five years is projected to arrive at 13.59%. Sales growth past 5 years was measured at 13.10%.
UnitedHealth Group (UNH) stated 2nd quarter 2k19 results with continued well diversified strength in performance. “Our results in the quarter reflect strong and balanced performance from both Optum and UnitedHealthcare and are driven by the 320,000 women and men of UnitedHealth Group who focus every day on creating value for those we serve,” stated David S. Wichmann, chief executive officer of UnitedHealth Group.
- UnitedHealth Group’s second quarter 2k19 revenues grew $4.5B or 8.0 percent year-over-year to $60.6B, led by double-digit percentage revenue growth at UnitedHealthcare Medicare & Retirement, OptumRx and OptumHealth.
- Second quarter earnings from operations grew 12.8 percent or $540M year-over-year to $4.7B. Adjusted net earnings of $3.60 per share advanced 14.6 percent.
- Cash flows from operations were $5.9B in the quarter and $9.1B or 1.3x net income year to date.
- Second quarter medical cost trends remained well managed, with the revenue effect from the deferral of the health insurance tax driving the 120 basis point raise in the consolidated medical care ratio year-over-year to 83.1 percent. Favorable medical reserve development was $270M this quarter and days claims payable remained consistent at 49 days.
- The second quarter operating cost ratio of 13.9 percent improved 110 basis points from the same period last year, reflecting the deferral of the health insurance tax and continued effects of productivity advances and operating cost management disciplines.
- Higher investment and other income was driven by higher interest yields and investment balances, earnings from well-performing minority investments and a $100M venture investment gain.
- Second quarter dividend payments grew to $1.0B as the yearly dividend rate was raised 20 percent to $4.32 per share in June 2k19. In the second quarter, 6.4M shares were repurchased for $1.5B, bringing year-to-date purchases to 18.2M shares for $4.5B.
- Return on equity of 25.1 percent in the period continued to reflect the Company’s strong and diverse earnings profile and efficient capital base.
UnitedHealthcare grew second quarter 2k19 earnings from operations by 12.1 percent to $2.6B driven by revenue growth and strong cost disciplines. The business grew to serve 705,000 more people with medical benefits over the past year, including a greater mix of people with higher acuity needs, helping grow revenues by $2.7B, or 6.0 percent, to $48.6B in the quarter.
- UnitedHealthcare Employer & Individual revenues in second quarter 2k19 raised $324M year-over-year to $14.0B, as UnitedHealthcare served 615,000 more people with commercial benefits in the past year.
- UnitedHealthcare Medicare & Retirement second quarter 2k19 revenues grew by $2.0B or 10.6 percent to $20.9B. Medicare Advantage products grew to serve 400,000 more individual and employer-sponsored seniors year-over-year. Including those dually eligible for Medicare and Medicaid and served through UnitedHealthcare Community & State, total year-over-year growth in Medicare Advantage was 540,000 people.
- UnitedHealthcare Community & State revenues grew $440M or 4.1 percent to $11.2B in second quarter 2k19, driven by growth in people served with higher acuity needs. Second quarter membership declined 350,000 people year-over-year primarily Because of states adding more carriers and managing eligibility and proactive market withdrawals.
- UnitedHealthcare Global revenues in second quarter 2k19 were stable year-over-year at $2.5B.
EPS growth for this year is 28.30% and EPS growth for next year is expected to reach at 12.47%. EPS growth in past five years was 17.30% while EPS growth in next five years is projected to arrive at 13.59%. Sales growth past 5 years was measured at 13.10%.
)
